Tomasz Urbanek Selected Research

Lymphatic Diseases

8/2020	Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement.
4/2018	Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Urbanek Research Topics

Disease

6	Stroke (Strokes) 09/2017 - 03/2014
4	Ischemia 01/2020 - 03/2014
3	Thrombosis (Thrombus) 06/2016 - 01/2011
2	Varicose Veins (Varicose Vein) 12/2020 - 01/2015
2	Lymphatic Diseases 08/2020 - 04/2018
2	Pain (Aches) 08/2020 - 01/2012
2	Venous Thromboembolism 06/2016 - 01/2012
2	Inflammation (Inflammations) 04/2016 - 01/2015
2	Varicose Ulcer (Ulcer, Venous) 02/2016 - 08/2013
2	Ulcer 02/2016 - 01/2014
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2016 - 01/2014
2	Atrial Fibrillation 01/2016 - 09/2015
2	Leg Ulcer 01/2014 - 08/2013
2	Wounds and Injuries (Trauma) 01/2014 - 05/2011
1	Heart Failure 10/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Neoplasms (Cancer) 06/2016
1	Hypertrophy 04/2016
1	Hemorrhage 01/2016
1	Ischemic Stroke 04/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Necrosis 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Brain Ischemia (Cerebral Ischemia) 03/2014
1	Edema (Dropsy) 01/2014
1	Urinary Incontinence 01/2014
1	Stress Urinary Incontinence 01/2014
1	Intracranial Embolism 01/2014
1	Atherosclerotic Plaque (Atheroma) 01/2014
1	Venous Insufficiency 08/2013
1	Embolism (Embolus) 01/2012
1	Pulmonary Embolism 01/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2012
1	Thromboembolism 01/2012

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 01/2020 - 01/2015
2	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 01/2020 - 04/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 03/2014
2	Oxygen (Dioxygen)IBA 01/2016 - 03/2014
2	RivaroxabanIBA 01/2016 - 01/2016
2	Neuroprotective AgentsIBA 04/2015 - 03/2014
2	Pharmaceutical PreparationsIBA 01/2015 - 03/2014
1	Heparinoids (Heparinoid)IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 06/2016
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2016
1	Troponin IIBA 09/2015
1	Glutamic Acid (Glutamate)FDA Link 04/2015
1	FlavonoidsIBA 01/2015
1	EnzymesIBA 01/2015
1	Endothelin-1 (Endothelin 1)IBA 01/2015
1	Free RadicalsIBA 01/2015
1	Sirolimus (Rapamycin)FDA Link 03/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Prothrombin (Factor II)IBA 01/2012
1	Factor X (Stuart Factor)IBA 01/2012
1	AnticoagulantsIBA 01/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2011

Therapy/Procedure

10	Therapeutics 10/2020 - 01/2012
2	Thrombectomy 09/2017 - 04/2015
2	Stents 01/2014 - 01/2011
1	Spinal Anesthesia 12/2020
1	Compression Stockings 04/2018
1	Punctures 09/2017
1	Duration of Therapy 06/2016
1	Drug Therapy (Chemotherapy) 06/2016
1	Secondary Prevention 01/2016
1	Embolectomy 04/2015
1	Suburethral Slings (Tension-Free Vaginal Tape) 01/2014
1	Endarterectomy (Thromboendarterectomy) 01/2014
1	Bandages (Bandage) 01/2014
1	Perioperative Period 01/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2014
1	Intermittent Pneumatic Compression Devices 01/2014
1	Preoperative Period 01/2014
1	Conduction Anesthesia (Regional Anesthesia) 01/2012
1	Thrombolytic Therapy 01/2012